Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country

CONCLUSION: Most pediatric cancer patients with COVID-19 should have good clinical outcomes except for patients with critical infections. Cancer patients can tolerate chemotherapy including induction phase, alongside COVID-19 treatment. In severe and critical COVID-19, RDV might have a potential benefit.PMID:34420893 | PMC:PMC8312090 | DOI:10.1016/j.clml.2021.07.025

Source: Clinical Lymphoma and Myeloma - August 23, 2021 Category: Cancer & Oncology Authors: Mahmoud Hammad Lobna Shalaby Iman Sidhom Nancy Sherief Ibrahim Abdo Sonia Soliman Youssef Madeny Reem Hassan Shaimaa Elmeniawy Nagwa Khamis Iman Zaki Tarek Mansour Mohamed Gamal El-Ansary Ahmed Al-Halfawy Sherif Abouelnaga Alaa Elhaddad Source Type: research